Cellebrite Di Ltd. (CLBT)

$11.2

-0.19

(-1.67%)

Market is closed - opens 8 PM, 21 Feb 2024

Insights on Cellebrite Di Ltd.

  • Increasing Revenue

    Revenue is up for the last 7 quarters, 62.38M → 84.17M (in $), with an average increase of 4.8% per quarter

  • Increasing Revenue

    Revenue is up for the last 7 quarters, 62.38M → 84.17M (in $), with an average increase of 4.8% per quarter

  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -32.34M → 6.5M (in $), with an average increase of 597.7% per quarter

  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -32.34M → 6.5M (in $), with an average increase of 597.7% per quarter

Performance

  • $10.90
    $11.59
    $11.20
    downward going graph

    2.68%

    Downside

    Day's Volatility :5.95%

    Upside

    3.36%

    downward going graph
  • $5.22
    $11.45
    $11.20
    downward going graph

    53.39%

    Downside

    52 Weeks Volatility :54.41%

    Upside

    2.18%

    downward going graph

Returns

PeriodCellebrite Di Ltd.Sector (Technology)Index (Russel 2000)
3 Months
42.73%
9.2%
0.0%
6 Months
54.34%
22.8%
0.0%
1 Year
97.06%
44.9%
-9.1%
3 Years
11.12%
48.9%
-22.0%

Highlights

Market Capitalization
2.1B
Book Value
$0.2
Earnings Per Share (EPS)
-0.32
Wall Street Target Price
10.17
Profit Margin
-18.86%
Operating Margin TTM
16.01%
Return On Assets TTM
5.48%
Return On Equity TTM
-121.92%
Revenue TTM
314.7M
Revenue Per Share TTM
1.68
Quarterly Revenue Growth YOY
11.600000000000001%
Gross Profit TTM
219.9M
EBITDA
46.8M
Diluted Eps TTM
-0.32
Quarterly Earnings Growth YOY
-0.77
EPS Estimate Current Year
0.25
EPS Estimate Next Year
0.26
EPS Estimate Current Quarter
0.05
EPS Estimate Next Quarter
0.05

Analyst Recommendation

Buy
    76%Buy
    23%Hold
    0
    0%Sell
Based on 13 Wall street analysts offering stock ratings for Cellebrite Di Ltd.(by analysts ranked 0 to 5 stars)
Based on 13 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
10
10
10
Hold
3
3
3
Sell
00
00
00

Analyst Forecast

What analysts predicted

Downside of 9.2%

Current $11.20
Target $10.17

Company Financials

FY19Y/Y Change
Revenue
171.9M
-
Net Income
-1.9M
-
Net Profit Margin
-1.09%
-
FY20Y/Y Change
Revenue
194.9M
↑ 13.42%
Net Income
5.8M
↓ 408.16%
Net Profit Margin
2.97%
↑ 4.06%
FY21Y/Y Change
Revenue
246.2M
↑ 26.34%
Net Income
71.4M
↑ 1135.01%
Net Profit Margin
28.99%
↑ 26.02%
FY22Y/Y Change
Revenue
270.7M
↑ 9.91%
Net Income
120.8M
↑ 69.2%
Net Profit Margin
44.63%
↑ 15.64%
FY23Y/Y Change
Revenue
306.1M
↑ 13.1%
Net Income
-59.4M
↓ 149.15%
Net Profit Margin
-19.4%
↓ 64.03%
Q2 FY22Q/Q Change
Revenue
62.6M
↑ 0.3%
Net Income
33.2M
↓ 40.12%
Net Profit Margin
53.05%
↓ 35.81%
Q3 FY22Q/Q Change
Revenue
71.7M
↑ 14.55%
Net Income
25.1M
↓ 24.41%
Net Profit Margin
35.01%
↓ 18.04%
Q4 FY22Q/Q Change
Revenue
74.0M
↑ 3.27%
Net Income
7.1M
↓ 71.79%
Net Profit Margin
9.56%
↓ 25.45%
Q1 FY23Q/Q Change
Revenue
74.0M
↑ 0.0%
Net Income
7.1M
↑ 0.0%
Net Profit Margin
9.56%
↑ 0.0%
Q2 FY23Q/Q Change
Revenue
76.7M
↑ 3.6%
Net Income
-32.3M
↓ 557.02%
Net Profit Margin
-42.18%
↓ 51.74%
Q3 FY23Q/Q Change
Revenue
84.2M
↑ 9.77%
Net Income
6.5M
↓ 120.09%
Net Profit Margin
7.72%
↑ 49.9%
FY19Y/Y Change
Total Assets
280.2M
-
Total Liabilities
221.4M
-
FY20Y/Y Change
Total Assets
364.4M
↑ 30.03%
Total Liabilities
300.6M
↑ 35.76%
FY21Y/Y Change
Total Assets
339.8M
↓ 6.75%
Total Liabilities
413.1M
↑ 37.44%
FY22Y/Y Change
Total Assets
403.3M
↑ 18.69%
Total Liabilities
329.4M
↓ 20.26%
Q2 FY22Q/Q Change
Total Assets
324.8M
↑ 0.07%
Total Liabilities
300.8M
↓ 10.71%
Q3 FY22Q/Q Change
Total Assets
352.5M
↑ 8.51%
Total Liabilities
293.0M
↓ 2.58%
Q4 FY22Q/Q Change
Total Assets
403.3M
↑ 14.41%
Total Liabilities
329.4M
↑ 12.42%
Q1 FY23Q/Q Change
Total Assets
403.3M
↑ 0.0%
Total Liabilities
329.4M
↑ 0.0%
Q2 FY23Q/Q Change
Total Assets
425.9M
↑ 5.6%
Total Liabilities
408.3M
↑ 23.95%
Q3 FY23Q/Q Change
Total Assets
476.9M
↑ 11.99%
Total Liabilities
439.0M
↑ 7.51%
FY19Y/Y Change
Operating Cash Flow
16.1M
-
Investing Cash Flow
-46.7M
-
Financing Cash Flow
75.5M
-
FY20Y/Y Change
Operating Cash Flow
66.5M
↑ 312.26%
Investing Cash Flow
-6.4M
↓ 86.2%
Financing Cash Flow
-8.6M
↓ 111.38%
FY21Y/Y Change
Operating Cash Flow
36.1M
↓ 45.79%
Investing Cash Flow
45.2M
↓ 801.29%
Financing Cash Flow
-68.4M
↑ 695.96%
FY22Y/Y Change
Operating Cash Flow
20.6M
↓ 42.92%
Investing Cash Flow
-91.2M
↓ 301.72%
Financing Cash Flow
14.0M
↓ 120.42%
Q2 FY22Q/Q Change
Operating Cash Flow
-4.1M
↓ 61.35%
Investing Cash Flow
-28.6M
↑ 113.37%
Financing Cash Flow
1.1M
↓ 70.75%
Q3 FY22Q/Q Change
Operating Cash Flow
-556.0K
↓ 86.35%
Investing Cash Flow
-11.8M
↓ 58.74%
Financing Cash Flow
7.3M
↑ 587.84%
Q4 FY22Q/Q Change
Operating Cash Flow
35.7M
↓ 6528.6%
Investing Cash Flow
-37.4M
↑ 217.42%
Financing Cash Flow
2.0M
↓ 72.81%
Q1 FY23Q/Q Change
Operating Cash Flow
35.7M
↑ 0.0%
Investing Cash Flow
-10.7M
↓ 71.31%
Financing Cash Flow
2.0M
↑ 0.0%
Q2 FY23Q/Q Change
Operating Cash Flow
16.6M
↓ 53.62%
Investing Cash Flow
-10.7M
↑ 0.0%
Financing Cash Flow
5.7M
↑ 186.74%
Q3 FY23Q/Q Change
Operating Cash Flow
29.2M
↑ 76.03%
Investing Cash Flow
-10.9M
↑ 1.42%
Financing Cash Flow
8.8M
↑ 54.97%

Technicals Summary

Sell

Neutral

Buy

Cellebrite Di Ltd. is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Cellebrite Di Ltd.
Cellebrite Di Ltd.
27.55%
54.34%
97.06%
11.12%
11.12%
Microsoft Corporation
Microsoft Corporation
1.9%
25.53%
59.92%
72.3%
277.1%
Adobe Systems Inc.
Adobe Systems Inc.
-9.43%
5.03%
57.68%
16.98%
111.8%
Oracle Corp.
Oracle Corp.
1.1%
-4.53%
29.13%
72.71%
115.01%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Cellebrite Di Ltd.
Cellebrite Di Ltd.
69.09
NA
NA
0.25
-1.22
0.05
NA
0.2
Microsoft Corporation
Microsoft Corporation
36.76
36.76
2.37
11.65
0.39
0.15
0.01
32.06
Adobe Systems Inc.
Adobe Systems Inc.
49.99
49.99
2.2
17.94
0.36
0.15
NA
36.3
Oracle Corp.
Oracle Corp.
31.15
31.15
1.18
5.55
0.34
0.07
0.01
1.41
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Cellebrite Di Ltd.
Cellebrite Di Ltd.
Buy
$2.1B
11.12%
69.09
-18.86%
Microsoft Corporation
Microsoft Corporation
Buy
$3.0T
277.1%
36.76
36.27%
Adobe Systems Inc.
Adobe Systems Inc.
Buy
$266.9B
111.8%
49.99
27.97%
Oracle Corp.
Oracle Corp.
Buy
$310.0B
115.01%
31.15
19.64%

Institutional Holdings

  • True Wind Capital Management, L.P.

    6.78%
  • Phoenix Holdings Ltd

    6.10%
  • Clal Insurance Enterprises Holdings Ltd

    3.33%
  • Greenhaven Road Investment Management, L.P.

    3.21%
  • Crosslink Capital Inc

    1.62%
  • MAKENA CAPITAL MANAGEMENT LLC

    1.60%

Company Information

Cellebrite is an Israeli digital intelligence company that provides tools for federal, state, and local law enforcement as well as enterprise companies and service providers to collect, review, analyze and manage digital data.

Organization
Cellebrite Di Ltd.
Employees
1005
CEO
Mr. Yossi Carmil
Industry
Technology

FAQs